OpenVSafe by OpenVAERS
Search V-safe

AN7-23953-76219

2 vaccinations 3 coded responses 8 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
725 / AR
Registered
2021-03-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-21
    Dose 1 — Moderna
  2. 2021-02-20
    Dose 2 — Moderna
  3. 2021-03-12
    Registered in v-safe
  4. 2021-03-12
    Survey response — day 14, dose 2
    MedDRA: Glomerular filtration rate decreased — Feeling: Good
    Free text: On routine labs EGFR 10/20/20 67On routine labs EGFR 02/25/21. 56Have F/u to have rechecked 05/26/21
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  6. 2021-03-20
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  7. 2021-03-27
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  8. 2021-04-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-05-24
    Survey response — 3 months, dose 2
    MedDRA: Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Kidney function tests always normal prior to Moderna. Normal range EGFR >59, EGFR 12/20/20 67 #1 moderna 1/21/21 #2 Moderna 2/20/21 ,5days later 2/25/21 EGFR 56. Repeat EGFR 5/21/21 ; 56
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-05-24
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  11. 2021-08-25
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  12. 2022-02-20
    Survey response — 12 months, dose 2
    MedDRA: Blood creatinine decreased, Glomerular filtration rate increased, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: ModernaBooster 11/11/21 Labs 11/23/21 Bun range 6-20. My result 20 Creatinine range 0.4-1.0 1.0 Egfr > 60. 55.2 · Healthcare visit (other): Repeat labs scheduled for March 7, 2022
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-02-20
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  14. 2022-03-24

Vaccinations

DoseDateManufacturerCo-administered
12021-01-21Moderna
22021-02-20Moderna

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 5 — day 14, dose 2

2021-03-12

Symptoms: On routine labs EGFR 10/20/20 67On routine labs EGFR 02/25/21. 56Have F/u to have rechecked 05/26/21

Release 8 — 3 months, dose 2

2021-05-24

Symptoms: Kidney function tests always normal prior to Moderna. Normal range EGFR >59, EGFR 12/20/20 67 #1 moderna 1/21/21 #2 Moderna 2/20/21 ,5days later 2/25/21 EGFR 56. Repeat EGFR 5/21/21 ; 56

Release 11 — 12 months, dose 2

2022-02-20

Symptoms: ModernaBooster 11/11/21 Labs 11/23/21 Bun range 6-20. My result 20 Creatinine range 0.4-1.0 1.0 Egfr > 60. 55.2
Healthcare visit (other): Repeat labs scheduled for March 7, 2022

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDBlood creatinine decreased · · ✓
SDGlomerular filtration rate decreased ✓ ✓ ✓
SDGlomerular filtration rate increased · · ✓
SDUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release